These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4954932)

  • 1. Optic neuritis with prolonged use of chloramphenicol. Case report and relationship to fundus changes in cystic fibrosis.
    Cocke JG; Brown RE; Geppert LJ
    J Pediatr; 1966 Jan; 68(1):27-31. PubMed ID: 4954932
    [No Abstract]   [Full Text] [Related]  

  • 2. [Optic neuritis as a complication to treatment of cystic fibrosis with chloramphenicol].
    Nielsen EL
    Ugeskr Laeger; 1972 Oct; 134(44):2328-9. PubMed ID: 5087293
    [No Abstract]   [Full Text] [Related]  

  • 3. Optic neuritis and optic atrophy following chloramphenicol in cystic fibrosis patients.
    Harley RD; Huang NN; Macri CH; Green WR
    Trans Am Acad Ophthalmol Otolaryngol; 1970; 74(5):1011-31. PubMed ID: 5506851
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual disturbances in cystic fibrosis following chloramphenicol administration.
    Huang NN; Harley RD; Promadhattavedi V; Sproul A
    J Pediatr; 1966 Jan; 68(1):32-44. PubMed ID: 5901344
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
    Steinkamp G
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloramphenicol optic neuritis. Apparent protective effects of very high daily doses of pyridoxine and cyanocobalamin.
    Cocke JG
    Am J Dis Child; 1967 Oct; 114(4):424-6. PubMed ID: 6047242
    [No Abstract]   [Full Text] [Related]  

  • 7. Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered.
    Jones AM
    Eur Respir J; 2005 Sep; 26(3):373-5. PubMed ID: 16135714
    [No Abstract]   [Full Text] [Related]  

  • 8. Chloramphenicol optic neuropathy.
    Godel V; Nemet P; Lazar M
    Arch Ophthalmol; 1980 Aug; 98(8):1417-21. PubMed ID: 7417077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Pseudomonas aeruginosa in cystic fibrosis in a child].
    Selimović A; Saracević E; Mujicić E; Dizdarević A
    Med Arh; 2006; 60(1):68-9. PubMed ID: 16425540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis.
    Littlewood JM; Miller MG; Ghoneim AT; Ramsden CH
    Lancet; 1985 Apr; 1(8433):865. PubMed ID: 2858720
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.
    Antoniu S
    Expert Rev Anti Infect Ther; 2015 Jul; 13(7):897-905. PubMed ID: 25921312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled antibiotics in cystic fibrosis.
    Wall MA; Terry AB; Eisenberg J; McNamara M; Cohen R
    Lancet; 1983 Jun; 1(8337):1325. PubMed ID: 6134106
    [No Abstract]   [Full Text] [Related]  

  • 14. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
    Eber E; Thalhammer GH; Zach MS
    Eur Respir J; 2006 Feb; 27(2):438-9. PubMed ID: 16452606
    [No Abstract]   [Full Text] [Related]  

  • 15. 50 Years Ago in The Journal of Pediatrics: Visual Disturbances in Cystic Fibrosis following Chloramphenicol Administration.
    Long SS
    J Pediatr; 2016 Jan; 168():184. PubMed ID: 26719181
    [No Abstract]   [Full Text] [Related]  

  • 16. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
    Michalsen H; Bergan T
    Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of ceftriaxone-resistant strains of Pseudomonas aeruginosa in cystic fibrosis patients.
    Paull A; Morgan JR
    J Antimicrob Chemother; 1986 Nov; 18(5):635-9. PubMed ID: 3100487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis.
    Amin R; Lam M; Dupuis A; Ratjen F
    Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.